Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Ghrelin Repeated Dose Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating repeated-dose ghrelin for frailty in aging; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ghrelin (ghrelin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Frailty in Aging | Phase 2 | Status: COMPLETED | Results posted: 2015-10-08